REGENERON PHARMACEUTICALS, INC.: cash_and_restricted_cash
| Value | {"amount": 930400000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2018-06-30) |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3ea5d688-befc-43c6-bc33-cdeab5e7fbcc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001532176-19-000026Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/cash-and-restricted-cash/2018-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3ea5d688-befc-43c6-bc33-cdeab5e7fbcc
History
- supersedes {"amount": 930376000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} (evidence 0001532176-18-000028)